Table 1. CSE1L expression status n (%).
Clinicopathologic parameters | CSE1L expression level |
p value | |||
---|---|---|---|---|---|
Negative | Low | Middle | Strong | ||
Gender | 0.266 | ||||
Male | 49 | 21 | 15 | 13 | |
Female | 30 | 6 | 12 | 11 | |
Age (years) | 0.105 | ||||
<18 | 42 | 10 | 15 | 7 | |
≥18 | 37 | 17 | 12 | 17 | |
Location | 0.521 | ||||
Femur | 40 | 12 | 14 | 16 | |
Tibia | 25 | 8 | 9 | 7 | |
Elsewhere | 14 | 7 | 4 | 1 | |
Tumor necrosis rate (%) | 0.062 | ||||
<90 | 63 | 15 | 22 | 19 | |
≥90 | 16 | 12 | 5 | 5 | |
Cortical destruction | 0.206 | ||||
Yes | 64 | 26 | 24 | 19 | |
No | 15 | 1 | 3 | 5 | |
Recurrence | 0.000* | ||||
Yes | 25 | 12 | 11 | 21 | |
No | 54 | 15 | 16 | 3 | |
Metastasis | 0.175 | ||||
Yes | 45 | 21 | 17 | 12 | |
No | 34 | 6 | 10 | 12 | |
Enneking stage | 0.001* | ||||
II | 61 | 17 | 14 | 8 | |
III | 18 | 10 | 13 | 16 |
*P < 0.05.